THIRD HARMONIC BIO INC. - COMMON STOCK

Third Harmonic Bio to Participate in Upcoming Investor Conferences in November

07 11 2024 16:00:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

07 11 2024 08:10:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences in September

10 9 2024 16:00:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences

26 8 2024 16:00:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

08 8 2024 08:05:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference

28 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

15 5 2024 08:05:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

28 3 2024 08:30:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

26 3 2024 08:05:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference

26 2 2024 16:00:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update

04 1 2024 08:00:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2023 Financial Results

09 11 2023 08:30:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Leadership Changes

31 10 2023 08:30:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference

31 8 2023 08:30:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2023 Financial Results

10 8 2023 08:10:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

25 7 2023 08:30:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2023 Financial Results

11 5 2023 17:00:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results

29 3 2023 08:05:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria

15 12 2022 07:00:01 提供 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference

21 11 2022 16:05:00 提供 Nasdaq GlobeNewswire